The Firm represented the underwriters, led by Barclays Capital, Citi, BofA Merrill Lynch and Goldman, Sachs, in a public offering of $350 million principal amount of 1.125% Notes due 2014 and $650 million principal amount of Floating Rate Notes due 2014 of Target Corporation.
Tags: Simpson Thacher & Bartlett LLP Monthly Archives: July 2011
Baker & McKenzie Advises City of Kyiv on USD300 Million Offering
Baker & McKenzie announced today that it has acted as US, English and Ukrainian law counsel to the City of Kyiv on its offering of USD300 million loan participation notes.
Tags: Baker & McKenzie LLP Shearman & Sterling Advises Dow Chemical on $20 Billion Joint Venture with Saudi Aramco
Shearman & Sterling is representing longstanding client The Dow Chemical Company in its joint venture with Saudi Arabian Oil Company (Saudi Aramco) to build a $20 billion petrochemical plant at the Persian Gulf port of Jubail.
Tags: Shearman & Sterling LLP Davis Polk Advises Murphy Oil on Wisconsin Refinery Sale
Davis Polk is advising Murphy Oil Corporation in connection with the sale by its wholly owned subsidiary, Murphy Oil USA, Inc., of its refinery in Superior, Wisconsin, and related assets, to Calumet Specialty Products Partners, L.P. for a sales price of $214 million plus the value of hydrocarbon inventory, and subject to certain other adjustments. The hydrocarbon inventory will be valued based on market prices at closing (the inventory was valued at approximately $260 million as of June 30, 2011). The transaction, which is expected to close later in the third quarter or fourth quarter of 2011, is subject to customary regulatory approvals and conditions.
Tags: Davis Polk & Wardwell Simmons & Simmons Advises Rothschild, Evolution Securities and Peel Hunt on Merger
Simmons & Simmons is advising Rothschild as joint sponsor and financial adviser and Evolution Securities and Peel Hunt as joint sponsors and brokers to Wichford P.L.C (“Wichford”) on the £208.7 million acquisition of Redefine International plc (“Redefine”) by Wichford, and the listing of the enlarged property investment company on the Main Market of the London Stock Exchange.
Tags: Simmons & Simmons Simmons & Simmons Advises Kentz Corporation Limited on its Move from AIM to the Main Market
Simmons & Simmons has advised Kentz Corporation Limited, the holding company of the Kentz engineering and construction group, on the listing of its ordinary shares on the Official List of the UK Listing Authority with a premium listing and admission to trading on the London Stock Exchange plc’s main market for listed securities.
Tags: Simmons & Simmons WOLF THEISS Advises PUMA on Conversion Into SE
WOLF THEISS has advised the sportswear manufacturer PUMA in seven countries on the foundation of a European Company (Societas Europaea/SE) by conversion. WOLF THEISS thus underscore their expertise in international corporate law.
Clifford Chance Signals Commitment to the African Markets and Confirms Intention to Open in Morocco
Clifford Chance has today announced that its new office in Casablanca will open by the end of 2011. This is the next stage in the Firm’s plans to extend its existing strong Africa practice. The office will be the Firm’s first in Africa and will act as a hub for clients across the wider North African and Sub-Saharan Francophone region.
Tags: Clifford Chance LLP Baker & McKenzie Advises Canada Pension Plan Investment Board on its First Direct Real Estate Investment in Hong Kong
Baker & McKenzie recently acted for the Canada Pension Plan Investment Board (“CPPIB”) on its acquisition of 50% of the shares in Hong Kong Interlink from Goodman Group, one of the world’s largest listed fund managers specializing in industrial and business properties with whom CPPIB has a long-standing relationship. The gross purchase price of CPPIB’s interest is approximately CAD285 million (HKD2.26 billion). CPPIB is making an equity commitment of approximately CAD205 million and assuming debt of approximately CAD80 million to purchase the 50% interest. The other 50% of Hong Kong Interlink will be owned by the Goodman Hong Kong Logistics Fund.
Tags: Baker & McKenzie LLP | Hong Kong Cooley Advises Amira Pharmaceuticals on its $325 Million Sale to Bristol-Myers Squibb
Bristol-Myers Squibb Company (NYSE:BMY) and Amira Pharmaceuticals, Inc., announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.
Tags: Cooley LLP